Page last updated: 2024-10-22

alfuzosin and Urethral Obstruction

alfuzosin has been researched along with Urethral Obstruction in 2 studies

alfuzosin: structure given in first source

Urethral Obstruction: Partial or complete blockage in any part of the URETHRA that can lead to difficulty or inability to empty the URINARY BLADDER. It is characterized by an enlarged, often damaged, bladder with frequent urges to void.

Research Excerpts

ExcerptRelevanceReference
" The most frequently reported adverse event potentially related to alpha blockade was dizziness, which occurred in 5."2.41Alfuzosin: overview of pharmacokinetics, safety, and efficacy of a clinically uroselective alpha-blocker. ( Roehrborn, CG, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Höfner, K1
Claes, H1
De Reijke, TM1
Folkestad, B1
Speakman, MJ1
Roehrborn, CG1

Reviews

1 review available for alfuzosin and Urethral Obstruction

ArticleYear
Alfuzosin: overview of pharmacokinetics, safety, and efficacy of a clinically uroselective alpha-blocker.
    Urology, 2001, Volume: 58, Issue:6 Suppl 1

    Topics: Adrenergic alpha-Antagonists; Aged; Drug Administration Schedule; Humans; Male; Prostatic Hyperplasi

2001

Trials

1 trial available for alfuzosin and Urethral Obstruction

ArticleYear
Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    European urology, 1999, Volume: 36, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Drug Therapy, Combinati

1999